We’re still feeling all of the connection, collaboration, and community from FACTOR last month, and we can't wait to keep the momentum going! In this issue, we're sharing a FACTOR recap by JAB president Mackenzie. The MIB Agents Dino Tee is now available to order online! We also have an upcoming TURBO meeting and three OsteoBites episodes coming up this month. Plus, meet our 2026 OutSmarting Osteosarcoma grant recipients. We hope you'll join us as we continue building on the energy from FACTOR, and we're already looking forward to seeing you at FACTOR '27 in Rochester, Minnesota!
With hope,
The MIB Agents team
.png)
The MIB Agents Junior Advisory Board and NextGen play an important role in the FACTOR conference. From visiting Nationwide Children's Hospital labs to speaking on patient panels, these OsteoWarriors and OsteoSiblings bring the patient perspective to every part of the meeting. JAB President Mackenzie Maddry walks us through the FACTOR experience and shares what makes the conference so meaningful for young advocates.
.jpeg)
Meet your new favorite MIB Agents T-shirt — the Dino Tee!
After debuting as a FACTOR 2026 pre-launch exclusive and selling out on the first day of the conference, the Make Osteosarcoma Extinct Dino Tee is officially here!
This Sarcoma Awareness Month, share a dino-inspired reminder that osteosarcoma has a prehistoric history. Fun fact: the oldest known evidence of osteosarcoma was found in a dinosaur fossil dating back nearly 99 million years.
Wear your Dino Tee with pride, ROAR for awareness, and support MIB Agents’ mission to fund research toward better treatments and provide patient programs for families facing osteosarcoma. Together, we can help Make Osteosarcoma Extinct!
If you have a job posting and you would like it included here, please email christina@mibagents.org.
If you’re managing a patient with relapsed osteosarcoma and want additional perspectives on treatment strategies or clinical trial options, consider presenting the case at MIB Agents TURBO (Tumor Review Board for Osteosarcoma). TURBO meets via Zoom every two months, bringing together a global panel of osteosarcoma experts to review complex cases, exchange insights, and discuss emerging data. It’s a collegial, multidisciplinary forum designed to support clinical decision-making for challenging cases. This educational forum is for medical professionals only; patients and families are welcome to ask their oncologists to present a case on their behalf. Our next meeting is July 22nd at 5p ET.
Join TURBO to request an invite or submit a case.
Review shared learnings from our ASCO 2026 abstract: Uniting providers across institutions to support osteosarcoma care: Insights from 64 cases reviewed through the MIB agents TURBO board
.png)
Advancing translational liquid biopsy platforms to support early detection of metastasis in osteosarcoma
Epigenetic Regulation of the Type I Interferon Pathway in Osteosarcoma: Implications for Immune Checkpoint Blockade
.png)
July 30 | Jeremy Rosenblum, MD
Combinatorial immunotherapy to overcome cellular therapy resistance in osteosarcoma
Please join us in congratulating our OutSmarting Osteosarcoma 2026 grant recipients! Three recipients will receive $100,000 Hero grants:
Two recipients will receive a $50,000 Hope Young Investigator grant:
.png)
Veterinary Oncology is accepting submissions for a new special Collection focused on sarcoma research. The journal welcomes original research, reviews, and perspectives that advance the understanding, diagnosis, and treatment of sarcomas, including tumor biology, biomarkers, immunotherapy, targeted therapies, advanced imaging, and other emerging approaches. Contributions from the global veterinary and comparative oncology community are encouraged. The submission deadline is February 26, 2027.
.png)
